vTv Therapeutics (VTVT) Other Operating Expenses (2014 - 2016)
vTv Therapeutics (VTVT) reported Other Operating Expenses of $529000.0 for Q3 2016, down 9.57% on a YoY basis from $585000.0 in Q4 2015, and up 634.72% sequentially from $72000.0 in Q2 2016.
vTv Therapeutics (VTVT) Other Operating Expenses (2014 - 2016) Analysis & Trends
vTv Therapeutics (VTVT) has 3 years of Other Operating Expenses data on file, last reported at $529000.0 in Q3 2016.
- For the quarter ending Q3 2016, Other Operating Expenses fell 9.57% year-over-year to $529000.0; the trailing twelve-month figure through Jun 2017 stood at $529000.0 (down 68.25% YoY), and the FY2016 full-year result was $795000.0, down 66.13% from the prior year.
- Other Operating Expenses rose to $529000.0 in Q3 2016, from $72000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $815000.0 in Q4 2015 to a low of $72000.0 in Q2 2016.
- A 3-year average of $414000.0 and a median of $391000.0 in 2015 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses surged 178.16% in 2015 and tumbled 87.05% in 2016, its largest moves.
- Tracing VTVT's Other Operating Expenses over 3 years: stood at $293000.0 in 2014, then surged by 178.16% to $815000.0 in 2015, then sank by 35.09% to $529000.0 in 2016.
- Business Quant data shows VTVT's Other Operating Expenses at $529000.0 in Q3 2016, $72000.0 in Q2 2016, and $194000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | vTv Therapeutics | 19.27 Mn | 19.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 529,000.00 |
| Jun 30, 2016 | 72,000.00 |
| Mar 31, 2016 | 194,000.00 |
| Dec 31, 2015 | 815,000.00 |
| Sep 30, 2015 | 585,000.00 |
| Jun 30, 2015 | 556,000.00 |
| Mar 31, 2015 | 391,000.00 |
| Dec 31, 2014 | 293,000.00 |
| Sep 30, 2014 | 291,000.00 |